Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 3:30 AM ET

Date/Time Source News Release
11/11/2024 04:05 PM EST GlobeNewswire Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update
10/10/2024 05:50 AM EDT Business Wire Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
09/30/2024 04:05 PM EDT GlobeNewswire Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer
08/15/2024 07:45 PM EDT ACCESSWIRE Investors Have The Opportunity To Lead The Gritstone bio, Inc. Securities Fraud Lawsuit With The Schall Law Firm
08/13/2024 04:05 PM EDT GlobeNewswire Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
08/07/2024 07:50 PM EDT ACCESSWIRE Investors Are Invited To Take The Lead In The Gritstone Bio Inc Securities Fraud Case With The Schall Law Firm
08/06/2024 05:30 PM EDT ACCESSWIRE GRTS Investors Have The Opportunity To Lead Gritstone Bio Inc Securities Fraud Lawsuit With The Schall Law Firm
08/06/2024 03:45 PM EDT ACCESSWIRE Levi & Korsinsky Notifies Gritstone bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - GRTS
08/06/2024 03:30 PM EDT Newsfile GRTS DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important August 6 Deadline in Securities Class Action - GRTS
08/06/2024 10:00 AM EDT PR Newswire GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Page

Additional News

As of January 3, 2025 • 3:30 AM ET

Date/Time Source News Release
Page